Banque Cantonale Vaudoise Innoviva, Inc. Transaction History

Banque Cantonale Vaudoise

  • $2.43 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
SELL
$14.32 - $19.88 $2,720 - $3,777
-190 Reduced 4.69%
3,862 $57,000
Q3 2021

Oct 29, 2021
BUY
$13.06 - $17.24 $14,836 - $19,584
1,136 Added 38.96%
4,052 $68,000
Q2 2021

Aug 11, 2021
BUY
$11.45 - $13.96 $33,388 - $40,707
2,916 New
2,916 $39,000

Others Institutions Holding INVA

# of Institutions
228
Shares Held
79.1M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email